Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
Ipsen
Ipsen
Centre Hospitalier Universitaire Dijon
Methodist Health System
Huazhong University of Science and Technology
Children's Oncology Group
University of Nebraska
IRCCS San Raffaele
University Hospital, Strasbourg, France
National Institutes of Health Clinical Center (CC)
Massive Bio, Inc.
Hospices Civils de Lyon
IRCCS San Raffaele
Nanjing First Hospital, Nanjing Medical University
University of Roma La Sapienza
Western Sydney Local Health District
Jagiellonian University
European Institute of Oncology
Fujian Maternity and Child Health Hospital
Universidad Nacional Autonoma de Mexico
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Institute of Oncology
European Institute of Oncology
Sun Yat-sen University
Alberta Health services
Sociedad Española de Medicina Nuclear e Imagen Molecular
Insel Gruppe AG, University Hospital Bern